iCell Cardiac Fibroblasts

Unlock the full potential of cardiac research and disease modeling with iCell^® Cardiac Fibroblasts. Derived from induced pluripotent stem cells (iPSCs), these human cardiac fibroblasts support co-culture with isogenic iCell Cardiomyocytes to deliver unparalleled biological relevance.

Whether you are investigating cardiac remodeling, exploring the inflammatory response, or innovating novel therapeutics, you can trust iCell Cardiac Fibroblasts to advance your cardiac research.

• Consistent excellence Rigorous quality control processes and >98% human cardiac fibroblast purity ensure consistent results with every batch.
• Physiological function Terminally differentiated from human iPSCs, iCell Cardiac Fibroblasts display typical morphology and express relevant human cardiac fibroblast markers, including collagen 1, periostin, and connexin 43.
• Co-culture suitability Grow these iPSC-derived fibroblasts in monoculture or co-culture with isogenic iCell Cardiomyocytes to create powerful models for drug development and disease research.
• Versatile applications From wound healing to fibrosis and drug safety to extracellular matrix (ECM) turnover, iCell Cardiac Fibroblasts power diverse research.
• Efficient implementation Rapidly generate biologically relevant 2D or 3D cardiac microtissues by co-culturing these iPSC-derived fibroblasts directly from thaw.